NanoViricides (NNVC) to Release Earnings on Monday

NanoViricides (NYSEAMERICAN:NNVC) will be releasing its earnings data on Monday, February 12th.

NanoViricides (NYSEAMERICAN:NNVC) last issued its quarterly earnings data on Tuesday, November 14th. The company reported ($0.03) EPS for the quarter.

NanoViricides (NNVC) opened at $0.91 on Monday. The company has a market capitalization of $57.63, a PE ratio of -6.07 and a beta of 0.20. NanoViricides has a one year low of $0.83 and a one year high of $1.64.

Separately, BidaskClub cut NanoViricides from a “sell” rating to a “strong sell” rating in a research note on Saturday, November 4th.

TRADEMARK VIOLATION NOTICE: This article was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at

NanoViricides Company Profile

NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.

Earnings History for NanoViricides (NYSEAMERICAN:NNVC)

Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with's FREE daily email newsletter.

Leave a Reply